Publications

  •  
  • Oct. 12, 2016

    Enhanced F508del-CFTR Modulation with the S-nitrosoglutathione Reductase Inhibitor...

    View Poster
  •  
  • Mar. 18, 2016

    Enhanced F508del-CFTR Modulation with S-nitrosoglutathione...

    View Poster
  •  
  • Oct. 7, 2015

    The Pharmacokinetics of N91115 in Cystic Fibrosis Patients

    View Poster
  •  
  • Oct. 7, 2015

    Safety and Pharmacokinetics of N91115 in Patients with Cystic Fibrosis...

    View Poster
  •  
  • May 15, 2015

    A Novel Therapeutic Target in Asthma: Translational Evidence for Inhibition of...

    View Poster
  •  
  • May 15, 2015

    Enhanced CFTR modulation with a S-nitrosoglutathione reductase inhibitor...

    View Poster
  •  
  • October 9, 2014

    Safety, Tolerability, and Pharmacokinetics of the Oral S-Nitrosoglutathione Reductase...

    View Poster
  •  
  • October 9, 2014

    Safety, Tolerability, and Pharmacokinetics of the Intravenous...

    View Poster
  •  
  • October 4, 2014

    Pharmacological Correction and Acute Inhibition of GSNOR Results in Improved In Vitro...

    View Poster
  •  
  • March 21, 2014

    Primary airway epithelial cells expanded with feeder cells and ROCK inhibitor for screening...

    View Poster
  •  
  • March 21, 2014

    Identification of Novel, Efficacious F508del‐CFTR Correctors to Treat...

    View Poster
  •  
  • October 14, 2013

    Next generation F508del CFTR correctors using a YFP based high throughput...

    View Poster
  •  
  • October 14, 2013

    Intestinal Current Measurement to Assess Modulation of F508del-CFTR...

    View Poster
  •  
  • October 14, 2013

    A Novel GSNOR Inhibitor with Potent Bronchodilatory Effects and CFTR...

    View Poster
  •  
  • March 21, 2013

    S-nitrosoglutathione Reductase Inhibitors Modulate F508-del CFTR Protein...

    View Poster
  •  
  • March 20, 2013

    Small Molecule Inhibitors of GSNOR Possess Anti-Inflammatory and...

    View Poster
  •  
  • November 11, 2011

    S-Nitrosoglutathione Reductase Inhibitors for the Prevention and...

    View Poster
  •  
  • August 28, 2011

    Structure – Activity Relationships of Pyrrole Based S-Nitrosoglutathione...

    View Poster
  •  
  • July 14, 2011

    Heterozygous Deletion of S-Nitrosoglutathione Reductase in Mice Does Not...

    View Poster
  •  
  • May 3, 2011

    Oral S-Nitrosoglutathione Reductase Inhibitors Attenuate Pulmonary...

    View Poster
  •  
  • March 8, 2011

    Inhibition of the Enzyme S-Nitrosoglutathione (GSNO) Reductase Does Not...

    View Poster
  •  
  • September 1, 2010

    Discovery of S-nitrosoglutathione reductase (GSNOR) inhibitors as...

    View Poster
  •  
  • January 24, 2013

    Pharmacological Inhibition of S-Nitrosoglutathione Reductase Improves...

    Read Paper
  •  
  • December 28, 2012

    ADH IB Expression, but Not ADH III, Is Decreased in Human Lung Cancer...

    Read Paper
  •  
  • February 15, 2012

    Mechanism of Inhibition for N6022, a First-in-Class Drug Targeting...

    Read Paper
  •  
  • January 13, 2012

    Structure–activity relationship of pyrrole based S-nitrosoglutathione...

    Read Paper
  •  
  • August 25, 2011

    Preclinical 28-Day Inhalation Toxicity Assessment of S-Nitrosoglutathione...

    Read Paper
  •  
  • July 26, 2011

    Discovery of potent and novel S-nitrosoglutathione reductase inhibitors...

    Read Paper
  •  
  • April 19, 2011

    Structure–activity relationships of pyrrole based S-nitrosoglutathione...

    Read Paper
  •  
  • March 11, 2011

    Discovery of S-Nitrosoglutathione Reductase Inhibitors: Potential Agents...

    Read Paper

Leaving Nivalis.com

Nivalis Therapeutics is not responsible for the content on linked websites.

The document you requested is located on the Journal of Applied Physiology website. A subscription is required to view the document.